Vihinen M, Kwan S P, Lester T, Ochs H D, Resnick I, Väliaho J, Conley M E, Smith C I
Institute of Medical Technology, University of Tampere, Finland.
Hum Mutat. 1999;13(4):280-5. doi: 10.1002/(SICI)1098-1004(1999)13:4<280::AID-HUMU3>3.0.CO;2-L.
X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the gene coding for Bruton agammaglobulinemia tyrosine kinase (BTK). A database (BTKbase) of BTK mutations lists 544 mutation entries from 471 unrelated families showing 341 unique molecular events. In addition to mutations, a number of variants or polymorphisms have been found. Mutations in all the five domains of BTK cause the disease, the single most common event being missense mutations. Most mutations lead to truncation of the enzyme. The mutations appear almost uniformly throughout the molecule. About one-third of point mutations affect CpG sites, which usually code for arginine residues. The putative structural implications of all the missense mutations are provided in the database. BTKbase is available at http://www.uta.fi/imt/bioinfo.
X连锁无丙种球蛋白血症(XLA)是一种由布鲁顿无丙种球蛋白血症酪氨酸激酶(BTK)编码基因突变引起的免疫缺陷病。一个BTK突变数据库(BTKbase)列出了来自471个无亲缘关系家庭的544个突变条目,显示出341个独特的分子事件。除了突变外,还发现了一些变异或多态性。BTK所有五个结构域的突变都会导致该病,最常见的单一事件是错义突变。大多数突变会导致酶的截短。这些突变几乎均匀地出现在整个分子中。约三分之一的点突变影响CpG位点,这些位点通常编码精氨酸残基。数据库中提供了所有错义突变的推定结构影响。可通过http://www.uta.fi/imt/bioinfo访问BTKbase。